Evaluation of three commercial SARS-CoV-2 serology assays in a tertiary care hospital in the United Arab Emirates | Zendy

Adnan Alatoom | Zendy; Shereen H. Atef | Zendy; Laila AbdelWareth | Zendy; J. G. Murthy | Zendy; Matthew Jones | Zendy; Gerald F. Cox | Zendy; Jonathan M. Harris | Zendy; Basel Altrabulsi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of three commercial SARS-CoV-2 serology assays in a tertiary care hospital in the United Arab Emirates

Author(s) -

Adnan Alatoom,

Shereen H. Atef,

Laila AbdelWareth,

J. G. Murthy,

Matthew Jones,

Gerald F. Cox,

Jonathan M. Harris,

Basel Altrabulsi

Publication year - 2021

Publication title -

journal of infection and public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.983

H-Index - 35

eISSN - 1876-035X

pISSN - 1876-0341

DOI - 10.1016/j.jiph.2021.04.003

Subject(s) - seroconversion , serology , medicine , antibody , roche diagnostics , virology , covid-19 , tertiary care , immunology , infectious disease (medical specialty) , disease

Serology assays have the potential to support RT-PCR in the diagnosis of SARS-CoV-2 infection. We studied three commercially available immunoassays for their diagnostic accuracy from blood specimens collected from 93 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research